IFIA | International Federation of Inventors' Associations

Top Menu

  • IFIA EVENTS
  • Technology Transfer
  • Hall of Inventions
  • Inv.Title
  • Innovation Standard
  • IFIA Academy
  • Contact

Main Menu

  • About us
    • About IFIA
      • IFIA HISTORY
      • What is IFIA
      • Where IFIA work
      • ifia-offices-worldwide
      • IFIA’s MOU
      • IFIA Statutes
    • Governing Bodies
      • IFIA Structure
      • IFIA General Assembly
      • IFIA Executive Committee
    • IFIA President
    • Previous President
    • IFIA Registration
    • IFIA Partners
    • IFIA Relations
    • Contact us
  • Member
    • All Members
    • Full Members
    • Corresponding Members
    • Collaborating Members
    • Inv Title Members
    • IFIA Benefit
      • Organizations
      • Innovators
    • Become a Member
      • IFIA Membership Procedure
      • benefits and services
      • Member’s Obligations
  • Events
    • Event Schedule
      • UPCOMING EVENTS
      • Event Calendar
    • Event Report
    • World Creativity & Innovation Week
    • World Intellectual Property Day
    • World Inventor’s Day
    • IFIA World Congresses
    • Grants and Funding
  • Award
    • IFIA Best Invention Award
    • IFIA Memorial Medal
    • IFIA International Order of Merit
    • IFIA Cash Prize
    • IFIA Jury Board
  • Project
    • Inter-organizational
      • MIT Solve Programs and challenges
      • License Ideas and Inventions
      • AsiaIP Exchange
      • Online Marketplace
      • WIPO – IAP
      • WIPO – ADR
      • Green Inventions
      • IP Panorama
    • Intra-organizational
      • Innovation Standard
      • 2ICW Online Course
      • Hall of Inventions
      • Inv. Certificate
      • Inventor’s Day
      • World Competitions
  • Publication
    • IFIA News
    • IFIA Movies
    • IFIA Magazine
    • IFIA Picture Gallery
    • IFIA Activity Report
    • IFIA Scientific Articles
    • IFIA Books
    • IFIA Logo
    • IFIA Song
    • IFIA BANK ACCOUNT
    • Privacy Policy
  • Department
    • Technology Transfer
    • IFIA STARTUPS
    • IFIA Academy
    • Evaluation & Scoring
    • Women
    • Youth
    • African
    • Latin America
    • European
    • Middle East
  • IFIA EVENTS
  • Technology Transfer
  • Hall of Inventions
  • Inv.Title
  • Innovation Standard
  • IFIA Academy
  • Contact

logo

  • About us
    • About IFIA
      • IFIA HISTORY
      • What is IFIA
      • Where IFIA work
      • ifia-offices-worldwide
      • IFIA’s MOU
      • IFIA Statutes
    • Governing Bodies
      • IFIA Structure
      • IFIA General Assembly
        • Members
        • Meetings
      • IFIA Executive Committee
        • IFIA Executive Committee Members
        • IFIA Executive Committee Meeting
    • IFIA President
    • Previous President
    • IFIA Registration
    • IFIA Partners
    • IFIA Relations
    • Contact us
  • Member
    • All Members
    • Full Members
    • Corresponding Members
    • Collaborating Members
    • Inv Title Members
    • IFIA Benefit
      • Organizations
        • Associations, Organizers and Government Services
      • Innovators
        • Inventor and Innovation services
        • Grants and Funding
    • Become a Member
      • IFIA Membership Procedure
      • benefits and services
      • Member’s Obligations
  • Events
    • Event Schedule
      • UPCOMING EVENTS
      • Event Calendar
    • Event Report
    • World Creativity & Innovation Week
    • World Intellectual Property Day
    • World Inventor’s Day
    • IFIA World Congresses
    • Grants and Funding
  • Award
    • IFIA Best Invention Award
    • IFIA Memorial Medal
    • IFIA International Order of Merit
    • IFIA Cash Prize
    • IFIA Jury Board
  • Project
    • Inter-organizational
      • MIT Solve Programs and challenges
      • License Ideas and Inventions
      • AsiaIP Exchange
      • Online Marketplace
      • WIPO – IAP
      • WIPO – ADR
      • Green Inventions
      • IP Panorama
    • Intra-organizational
      • Innovation Standard
      • 2ICW Online Course
      • Hall of Inventions
      • Inv. Certificate
      • Inventor’s Day
      • World Competitions
  • Publication
    • IFIA News
    • IFIA Movies
    • IFIA Magazine
    • IFIA Picture Gallery
    • IFIA Activity Report
    • IFIA Scientific Articles
    • IFIA Books
    • IFIA Logo
    • IFIA Song
    • IFIA BANK ACCOUNT
    • Privacy Policy
  • Department
    • Technology Transfer
    • IFIA STARTUPS
    • IFIA Academy
    • Evaluation & Scoring
    • Women
    • Youth
    • African
    • Latin America
    • European
    • Middle East
  • Women and IP – World Intellectual Property Day – April 26, 2023

  • Side events at the 2023 UN Forum on Innovation for the SDGs in New York

  • IFIA 44th Executive Committee Meeting Held on 24 Feb 2023

  • IIFME 2023 -13th International Invention Fair of the Middle East

  • Official announcement for the 37th official session of the IFIA General Assembly

  • IFIA Innovation Standard Program was held in Switzerland

  • Successful Outcome for the IPITEX in Thailand Inventors’ Day 2023

  • IFIA Bharat Presented a Seminar in Mangalore, India

IFIA Articles
Home›IFIA Articles›Remdesivir associated sinus bradycardia in patients with COVID-19

Remdesivir associated sinus bradycardia in patients with COVID-19

By IFIA CH
March 8, 2023
31
0
Share:

Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study

IFIA Scientific Articles

Abstract

Background: Remdesivir is effective against SARS-Cov-2 with little evidence of its adverse effect on the cardiac system. The aim of the present study is to investigate the incidence of bradycardia in COVID-19 patients treated with Remdesivir.
Methods: This prospective longitudinal study was conducted in a tertiary center on COVID-19 patients for Remdesivir therapy. The objectives were to investigate the incidence of sinus bradycardia, and also the association between their demographics, underlying diseases, and the disease severity with developing bradycardia in COVID-19 patients treated with Remdesivir.

Conclusion: As sinus bradycardia is a prevalent adverse cardiac effect of Remdesivir, it is recommended that all COVID-19 patients receiving Remdesivir, be evaluated for heart rate based on examination; and in the case of bradyarrhythmia, cardiac monitoring should be performed during administration to prevent adverse drug reactions.
Keywords: remdesivir, bradycardia, COVID-19, arrhythmia, ECG, cardiotoxicity, SARS-CoV-2

Download Article

TagsARTICLESifia academyIFIA ArticlesIFIA ResearchIFIA Scientific ArticlesINV Titlescience
0
Shares
  • 0
  • +
  • 0
  • 0

IFIA OFFICE DIRECTION

IFIA’S MAIN SPONSOR

palexpo

IFIA HEADQUARTERS

Address: Palexpo, CP 112, Route François-Peyrot 30,1218 Le Grand-Saconnex, Geneva/Switzerland
Contact person:
Miss.Gaelle Grosjean
Tel : (+41) 22 761 11 11
Fax: (+41) 22 798 01 00
Email: info@ifia.com

Copyright © 1968-2023 International Federation of Inventors' Associations (IFIA). All Rights Reserved.